News Archives - Page 53 of 89

WednesdayMar 15, 2023 10:41 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Pens Latest Company Blog, Robot Roadshow to Make a Stop in Arizona

Knightscope (NASDAQ: KSCP) CEO William Santana authored the company’s latest blog release, titled “7 Questions About AI Robots.” In the blog, Li notes the accelerating trend of artificial intelligence (“AI”) being a part of everyday life, from cleaning and disinfecting to lawn care and security. Li says he is flooded with questions about AI, and the newest blog post becomes an ideal avenue for him to answer seven of the most common questions that people ask him about AI and Knightscope, including how the company currently uses the tech and the potential role AI has in future security applications. “As…

TuesdayMar 14, 2023 2:38 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Shares Insight into the Future of A.I.

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced a new blog on artificial intelligence (“A.I.”). The announcement reads, “As we enter the fourth industrial revolution, an era that will be defined and driven by extreme automation and ubiquitous connectivity, A.I. is altering the course of our future and the way we interact with technology and each other. Knightscope chairman and CEO, William Santana Li, answers seven questions about A.I., providing insight into how it is currently being used by the company, as well as its potential role in future security…

MondayMar 13, 2023 11:35 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that it is aware that the Federal Deposit Insurance Corp. has taken control of Silicon Valley Bank (“SVB”) due to liquidity concerns. CNS Pharmaceuticals does not hold any deposits or investments at SVB. To view the full press release, visit https://ibn.fm/4FTuQ About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the…

FridayMar 10, 2023 10:36 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ‘Optimus’ ASR for Fifth Year Running

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, announced that a long-time real estate client has renewed its K5 Autonomous Security Robot (“ASR”) contract for the fifth consecutive year. The announcement reads, “The client’s affectionately named ‘Optimus Crime’ ASR patrols a San Francisco Bay Area mixed-use parking structure to help protect the property, visitors and their vehicles. To learn more about how robots serve commercial real estate and to make properties more desirable for tenants and guests, read Knightscope’s recommendations for real estate investors/developers here.” To view the full press release, visit…

ThursdayMar 09, 2023 12:29 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that the first patient in Switzerland has been enrolled in the company’s ongoing global trial. The potentially pivotal trial is focused on evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. “The active patient enrollment we continue to build across our clinical trial sites in Europe is incredibly encouraging. Our team is laser focused on getting additional clinical trial sites online so that…

ThursdayMar 09, 2023 12:16 pm

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces 2022 Results, Emergence Among Leading US Producers of Critical Minerals

Energy Fuels (NYSE American: UUUU) (TSX: EFR) on Wednesday announced its financial results for the year ended Dec. 31, 2022. Among the highlights, the company reported a robust balance sheet with $116.97 million of working capital, including $62.80 million of cash and cash equivalents, $12.19 million of marketable securities, $38.16 million of inventory, and no debt. “2022 was an extraordinary year for Energy Fuels as we expanded our U.S. industry-leading uranium business and established a new, sustainable U.S. rare earth supply chain that is already commercially producing the most advanced rare earth material in the U.S. today,” said Mark S.…

ThursdayMar 09, 2023 12:04 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Existing Customer Order for Multiple K1 Call Boxes

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an additional order from Port Authority NY NJ. The order is for three new K1 call boxes, which the client plans to install at New York’s recently renovated Bayonne Bridge. An historic steel arch bridge connecting Staten Island, New York, with Bayonne, New Jersey, the Bayonne Bridge spans 7,160 feet across the Kill Van Kull tidal strait. The bridge is comprised of four lanes of traffic as well as a 12-foot-wide path that pedestrians, wheelchairs and bicyclists access 24/7. According to the…

ThursdayMar 09, 2023 11:34 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives NASDAQ Approval for 180-Day Extension to Meet Minimum $1 Bid Price

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that it received approval from NASDAQ of its 180-day extension request to meet the exchange’s $1 minimum bid price requirement. According to the announcement, Mullen received notice in September 2022 that its listed common stock no longer met NASDAQ’s minimum $1 bid price per share requirement. The company was given 180 calendar days, or until March 6, 2023, to regain compliance. The announcement also noted that if Mullen stock fails to trade above $1 for a minimum of 10 consecutive business days prior to Sept. 5, 2023, the company…

WednesdayMar 08, 2023 12:34 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Veteran of Media Industry as Chief Content, Engagement Officer

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has announced a new chief content and engagement officer. Maureen Connolly, an award-winning content strategic and audience builder, will step into the position. According to the announcement, Connolly has 20-plus years of experience in the health, wellness, science and technology sectors. She has proven expertise in working with product, marketing, and engineering teams to create content platforms that enable and encourage engagement between businesses and global audiences while also building supportive, connected communities. “Maureen’s background, experience and passion couldn’t be better…

WednesdayMar 08, 2023 12:15 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate at Oppenheimer 33rd Annual Health Care Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced that its Chief Executive Officer Doug Drysdale will participate at the Oppenheimer 33rd Annual Health Care Conference taking place on March 13-15, 2023. Drysdale’s fireside chat will be webcast live on Tuesday, March 14, at 12:40 p.m. ET. Interested parties should visit https://ibn.fm/4Qlqa to register for and access the webcast. The archived version will also be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/mdZjb About Cybin Inc. Cybin is a leading ethical biopharmaceutical company working with…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News